Skip to main content

Table 1 Characteristics of the studied groups

From: Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes

  Asthma Controls
n 44 18
Men/women [ n ] 19/25 11/7
Age [years] 53 (21-77) 41(20-71)
Period of observation [months] 62 (9-124) n.a.
FEV 1 [%] 79 (37-113) n.a.
PEF [l/s] 365 (223-610) n.a.
Exacerbations per year 0.97 (0-3.31) n.a.
Episodes of acute infection per year 0.49 (0-2.51) n.a.
Hospitalization for asthma per year 0 (0-0.83) n.a.
Nocturnal dyspnoe per year 0.36 (0-3.16) n.a.
ICS [μg per day] 1258 (158-3289) n.a.
Oral GCS [mg per day] 1.6 (0-10.6) n.a.
Oral GCS [days of use per year] 76.4 (0-365) n.a.
Montelukast [mg per day] 2.3 (0-10) n.a.
Zafirlukast [mg per day] 0 (0-26.1) n.a.
Smokers [%] 20.5 16.6
Atopy [%] 63 0.0
GERD [%] 2.6 0.0
Chronic rhinosinusitis [%] 20.5 0.0
Aspirin intolerance [%] 10.2 0.0
Allergic rhinitis [%] 59 0.0
  1. Variables are shown as median and range or percentage. n.a. - non applicable.